Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

12. Mai 2015 07:30 ET | Quelle: Melinta Therapeutics, Inc.

Cempra to Present Solithromycin Data at Two Upcoming Medical Conferences

CHAPEL HILL, N.C., May 12, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
30. April 2015 16:04 ET | Quelle: Melinta Therapeutics, Inc.

Cempra Reports First Quarter 2015 Financial Results and Provides Corporate Update

CHAPEL HILL, N.C., April 30, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
23. April 2015 07:30 ET | Quelle: Melinta Therapeutics, Inc.

Cempra to Report First Quarter 2015 Financial Results

CHAPEL HILL, N.C., April 23, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
17. April 2015 07:30 ET | Quelle: Melinta Therapeutics, Inc.

Cempra to Present at Two Upcoming Scientific Conferences

CHAPEL HILL, N.C., April 17, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
16. März 2015 17:21 ET | Quelle: Melinta Therapeutics, Inc.

Cempra to Participate in Jefferies 2015 Antibiotic Summit Investor Conference

CHAPEL HILL, N.C., March 16, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
25. Februar 2015 16:00 ET | Quelle: Melinta Therapeutics, Inc.

Cempra Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Corporate Update

CHAPEL HILL, N.C., Feb. 25, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
17. Februar 2015 08:00 ET | Quelle: Melinta Therapeutics, Inc.

Cempra to Report Fourth Quarter and Full Year 2014 Financial Results

CHAPEL HILL, N.C., Feb. 17, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
03. Februar 2015 08:00 ET | Quelle: Melinta Therapeutics, Inc.

Cempra to Present at Three Upcoming Investor Conferences

CHAPEL HILL, N.C., Feb. 3, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
13. Januar 2015 16:01 ET | Quelle: Melinta Therapeutics, Inc.

Cempra Announces Full Exercise of Additional Share Option and Completion of the Public Offering of Common Stock

CHAPEL HILL, N.C., Jan. 13, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
07. Januar 2015 20:00 ET | Quelle: Melinta Therapeutics, Inc.

Cempra Prices Public Offering of Common Stock

CHAPEL HILL, N.C., Jan. 7, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...

Vorherige Seite

Nächste Seite